Global Hematological Cancers Market Forecast to Rise $70.1 Billion by 2022, at a CAGR of 12.5% - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market: MarketResearchReports.Biz
Hematological malignancies are a class of cancer that affect the blood, lymph nodes and bone marrow. They include numerous forms of leukemia, lymphoma and myeloma. Hematological malignancies constituted 9% of all newly diagnosed malignancies in the US in 2011, with data indicating lymphomas are more prevalent than leukemias or myeloma. Excluding acute lymphocytic leukemia and Hodgkin's lymphoma, these types of malignancy are generally associated with increasing age. Therefore, considering the aging population globally, this class of malignancy is likely to...
View full press release